Find Arformoterol Tartrate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

4 RELATED EXCIPIENT COMPANIES

4EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 200815-49-2, Brovana, (r,r)-arformoterol tartrate, Arformoterol tartrate [usan], 5p8vj2i235, Arformoterol tartrate (usan)
Molecular Formula
C23H30N2O10
Molecular Weight
494.5  g/mol
InChI Key
FCSXYHUNDAXDRH-OKMNHOJOSA-N
FDA UNII
5P8VJ2I235

Arformoterol Tartrate
Arformoterol Tartrate is the tartrate salt of arformoterol, the (R,R)-enantiomer of formoterol and a long-acting beta-2 adrenergic agonist with bronchodilator activity. Arformoterol selectively binds to and activates beta-2 adrenergic receptors in bronchiolar smooth muscle, thereby causing stimulation of adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cAMP). Increased intracellular cAMP levels cause relaxation of bronchial smooth muscle and lead to an inhibition of release of inflammatory mediators from mast cells. This may eventually lead to an improvement of airway function.
1 2D Structure

Arformoterol Tartrate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2R,3R)-2,3-dihydroxybutanedioic acid;N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide
2.1.2 InChI
InChI=1S/C19H24N2O4.C4H6O6/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22;5-1(3(7)8)2(6)4(9)10/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22);1-2,5-6H,(H,7,8)(H,9,10)/t13-,19+;1-,2-/m11/s1
2.1.3 InChI Key
FCSXYHUNDAXDRH-OKMNHOJOSA-N
2.1.4 Canonical SMILES
CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O.C(C(C(=O)O)O)(C(=O)O)O
2.1.5 Isomeric SMILES
C[C@H](CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=C(C=C2)O)NC=O)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
2.2 Other Identifiers
2.2.1 UNII
5P8VJ2I235
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 200815-49-2

2. Brovana

3. (r,r)-arformoterol Tartrate

4. Arformoterol Tartrate [usan]

5. 5p8vj2i235

6. Arformoterol Tartrate (usan)

7. Formamide, N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, (2r,3r)-2,3-dihydroxybutanedioate (1:1)

8. (r,r)-formoterol Tartrate

9. (-)-n-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide Hydrogen (2r,3r)-2,3-dihydroxybutanedioate (salt)

10. Formamide, N-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)-, (2r,3r)-2,3-dihydroxybutanedioate (1:1) (salt)

11. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-formamide (2r,3r)-2,3-dihydroxybutanedioate (1:1) (salt)

12. Brovana Inhalation Solution

13. Unii-5p8vj2i235

14. Brovana (tn)

15. Arformotero Ltartrate

16. Dtxsid80173903

17. Arformoterol Tartrate [vandf]

18. S5217

19. Arformoterol Tartrate [mart.]

20. Akos005145740

21. Arformoterol Tartrate [who-dd]

22. Ccg-269651

23. Arformoterol Tartrate, >=98% (hplc)

24. Ba171831

25. Bs-42158

26. Arformoterol Tartrate [orange Book]

27. Formoterol R,r-form L-tartrate [mi]

28. D02981

29. 815f492

30. Q-101035

31. Q27262686

32. (2r,3r)-2,3-dihydroxybutanedioic Acid;n-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide

33. (r,r)-formoterol Tartrate; N-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide (2r,3r)-2,3-dihydroxybutanedioate (1:1)

34. [(2r)-2-(3-formamido-4-hydroxyphenyl)-2-hydroxyethyl]-[(2r)-1-(4-methoxyphenyl)propan-2-yl]azanium;(2r,3r)-2,3,4-trihydroxy-4-oxobutanoate

35. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide (2r,3r)-2,3-dihydroxybutane Dioate

36. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide (2r,3r)-2,3-dihydroxybutanedioate

37. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide L-tartrate

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 494.5 g/mol
Molecular Formula C23H30N2O10
Hydrogen Bond Donor Count8
Hydrogen Bond Acceptor Count11
Rotatable Bond Count11
Exact Mass494.19004516 g/mol
Monoisotopic Mass494.19004516 g/mol
Topological Polar Surface Area206 Ų
Heavy Atom Count35
Formal Charge0
Complexity521
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameBrovana
PubMed HealthArformoterol (By breathing)
Drug ClassesBronchodilator
Active IngredientArformoterol tartrate
Dosage FormSolution
RouteInhalation
Strengtheq 0.015mg base/2ml
Market StatusPrescription
CompanySunovion

2 of 2  
Drug NameBrovana
PubMed HealthArformoterol (By breathing)
Drug ClassesBronchodilator
Active IngredientArformoterol tartrate
Dosage FormSolution
RouteInhalation
Strengtheq 0.015mg base/2ml
Market StatusPrescription
CompanySunovion

5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
beta2-Adrenergic Agonist [EPC]; Adrenergic beta2-Agonists [MoA]

API SUPPLIERS

read-more
read-more

01

Inke S.A

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInke S.A: APIs manufacturing plant.

Flag Spain
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC arrow-down KDMF arrow-down VMF CN arrow-down AUDIT
Inke Company Banner

02

Inke S.A

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInke S.A: APIs manufacturing plant.

Flag Spain
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF arrow-down VMF CN arrow-down AUDIT
Inke Company Banner

03

MSN Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

World Vaccine Congress
Not Confirmed
arrow

MSN Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
World Vaccine Congress
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT
blank

04

Glenmark Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

World Vaccine Congress
Not Confirmed
arrow

Glenmark Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
World Vaccine Congress
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

05

Cipla

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

World Vaccine Congress
Not Confirmed
arrow

Cipla

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
World Vaccine Congress
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT
blank

06

Melody Healthcare Pvt Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

World Vaccine Congress
Not Confirmed
arrow

Melody Healthcare Pvt Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
World Vaccine Congress
Not Confirmed
USDMF CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
blank

07

Hunan Warrant Chiral Pharmaceutica...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

World Vaccine Congress
Not Confirmed
arrow

08

Glenmark Pharmaceuticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

World Vaccine Congress
Not Confirmed
arrow

Glenmark Pharmaceuticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
World Vaccine Congress
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Cipla

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

World Vaccine Congress
Not Confirmed
arrow

Cipla

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
World Vaccine Congress
Not Confirmed
USDMF CEP/COS JDMF EU-WCInactive-api NDC arrow-down KDMF VMF Others AUDIT
blank

10

Harman Finochem

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

World Vaccine Congress
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

01

Inke Sa

Spain
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInke S.A: APIs manufacturing plant.

Flag Spain
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2022-07-14

Pay. Date : 2022-03-17

DMF Number : 36435

Submission : 2022-05-16

Status : Active

Type : II

Inke Company Banner

02

Inke Sa

Spain
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInke S.A: APIs manufacturing plant.

Flag Spain
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2019-04-12

Pay. Date : 2018-07-17

DMF Number : 32990

Submission : 2018-07-25

Status : Active

Type : II

Inke Company Banner

03

Cipla Ltd

India

USDMF

arrow
SupplySide West 2024
Not Confirmed

03

Cipla Ltd

India
arrow
SupplySide West 2024
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-05-15

Pay. Date : 2014-05-02

DMF Number : 22968

Submission : 2009-08-19

Status : Active

Type : II

blank

04

SupplySide West 2024
Not Confirmed

04

SupplySide West 2024
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2015-06-09

Pay. Date : 2015-03-27

DMF Number : 28868

Submission : 2015-03-27

Status : Active

Type : II

blank

05

SupplySide West 2024
Not Confirmed

05

Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-more

01

Cipla

India
SupplySide West 2024
Not Confirmed
arrow

Cipla

India
arrow
SupplySide West 2024
Not Confirmed

Arformoterol Tartrate IH

Date of Issue : 2022-06-08

Valid Till : 2025-09-08

Written Confirmation Number : WC-0144

Address of the Firm : Plot. D-7 MIDC, Kurkumbh, Dist. Pune-413802

blank

02

Cipla

India
SupplySide West 2024
Not Confirmed
arrow

Cipla

India
arrow
SupplySide West 2024
Not Confirmed

Arformoterol Tartrate

Date of Issue : 2020-01-28

Valid Till : 2022-09-08

Written Confirmation Number : WC-0144A5

Address of the Firm : Plot. D-7 MIDC, Kurkumbh, Dist. Pune-413802

blank

03

SupplySide West 2024
Not Confirmed
arrow
arrow
SupplySide West 2024
Not Confirmed

Arformoterol Tartrate IH

Date of Issue : 2022-07-28

Valid Till : 2025-07-02

Written Confirmation Number : WC-0227

Address of the Firm : Plot No. J-73, MIDC, Tarapur, Boisar, Dist- Palghar 401506, Maharashtra, India

blank

04

SupplySide West 2024
Not Confirmed
arrow
arrow
SupplySide West 2024
Not Confirmed

Arformoterol Tartrate IH

Date of Issue : 2022-06-17

Valid Till : 2025-07-14

Written Confirmation Number : WC-0021n

Address of the Firm : Sy. Nos: 317, 320, 321, 322, 323, 604 & 605, Rudraram (Village), Patancheru (Man...

blank

05

SupplySide West 2024
Not Confirmed
arrow
arrow
SupplySide West 2024
Not Confirmed

Arformoterol Tartrate IH

Date of Issue : 2019-07-15

Valid Till : 2022-07-14

Written Confirmation Number : WC-0021

Address of the Firm : Sy. No.317&323, Rudraram Village, Patancheru Mandal, Sangaredy District-502329 T...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

The acquisition of Brovana® (arformoterol tartrate) Inhalation Solution and Xopenex HFA® (levalbuterol tartrate) Inhalation Aerosol brands expands Lupin’s portfolio of inhalation products in the U.S. and strengthens the company’s presence in the respiratory therapy area.


Lead Product(s): Arformoterol Tartrate

Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Brovana

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Lupin Ltd

Deal Size: $75.0 million Upfront Cash: Undisclosed

Deal Type: Acquisition October 20, 2022

blank

01

World Vaccine Congress
Not Confirmed
World Vaccine Congress
Not Confirmed

Details : The acquisition of Brovana® (arformoterol tartrate) Inhalation Solution and Xopenex HFA® (levalbuterol tartrate) Inhalation Aerosol brands expands Lupin’s portfolio of inhalation products in the U.S. and strengthens the company’s presence in the re...

Brand Name : Brovana

Molecule Type : Small molecule

Upfront Cash : Undisclosed

October 20, 2022

blank

Details:

Arformoterol Tartrate inhalation solution, EQ 0.015 mg Base/2 ml is indicated for the long-term, twice daily (morning and evening) maintenance treatment of bronchoconstriction in patients with COPD, including chronic bronchitis and emphysema.


Lead Product(s): Arformoterol Tartrate

Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Arformoterol Tartrate-Generic

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable August 24, 2022

blank

02

World Vaccine Congress
Not Confirmed
World Vaccine Congress
Not Confirmed

Details : Arformoterol Tartrate inhalation solution, EQ 0.015 mg Base/2 ml is indicated for the long-term, twice daily (morning and evening) maintenance treatment of bronchoconstriction in patients with COPD, including chronic bronchitis and emphysema.

Brand Name : Arformoterol Tartrate-Generic

Molecule Type : Small molecule

Upfront Cash : Not Applicable

August 24, 2022

blank

Details:

Cipla’s Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana®.


Lead Product(s): Arformoterol Tartrate

Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable June 23, 2021

blank

03

Cipla

India
arrow
World Vaccine Congress
Not Confirmed

Cipla

India
arrow
World Vaccine Congress
Not Confirmed

Details : Cipla’s Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana®.

Brand Name : Undisclosed

Molecule Type : Small molecule

Upfront Cash : Not Applicable

June 23, 2021

blank

Details:

Arformoterol Tartrate Inhalation Solution 15mcg/2mL, is indicated for the long-term, twice daily maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. It is for use by nebulization only.


Lead Product(s): Arformoterol Tartrate

Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable June 03, 2021

blank

04

Lupin Ltd

India
arrow
World Vaccine Congress
Not Confirmed

Lupin Ltd

India
arrow
World Vaccine Congress
Not Confirmed

Details : Arformoterol Tartrate Inhalation Solution 15mcg/2mL, is indicated for the long-term, twice daily maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. It is for us...

Brand Name : Undisclosed

Molecule Type : Small molecule

Upfront Cash : Not Applicable

June 03, 2021

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATES SUPPLIERS

read-more
read-more

01

SupplySide West 2024
Not Confirmed
arrow
SupplySide West 2024
Not Confirmed
arrow

CAS Number : 201677-59-0

End Use API : Arformoterol Tartrate

About The Company : Hiray Pharma Solutions is an international end-to-end CDMO, facilitating the development and manufacturing of important drug products and key intermediates arou...

blank

02

SupplySide West 2024
Not Confirmed
arrow
SupplySide West 2024
Not Confirmed
arrow

CAS Number : 188690-84-8

End Use API : Arformoterol Tartrate

About The Company : Hiray Pharma Solutions is an international end-to-end CDMO, facilitating the development and manufacturing of important drug products and key intermediates arou...

blank

03

SupplySide West 2024
Not Confirmed
arrow
SupplySide West 2024
Not Confirmed
arrow

CAS Number : 201677-59-0

End Use API : Arformoterol Tartrate

About The Company : With nearly seven decades of manufacturing expertise, Speichim Processing actively formulates circular economy strategies by reclaiming waste and chemical produ...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

Regulatory Info : RX

Registration Country : USA

ARFORMOTEROL TARTRATE

Brand Name : ARFORMOTEROL TARTRATE

Dosage Form : SOLUTION;INHALATION

Dosage Strength : EQ 0.015MG BASE/2ML

Packaging :

Approval Date : 2024-06-03

Application Number : 215032

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

02

World Vaccine Congress
Not Confirmed
arrow
arrow
World Vaccine Congress
Not Confirmed

ARFORMOTEROL TARTRATE

Brand Name : ARFORMOTEROL TARTRATE

Dosage Form : SOLUTION;INHALATION

Dosage Strength : EQ 0.015MG BASE/2ML

Packaging :

Approval Date : 2024-04-02

Application Number : 214901

Regulatory Info : RX

Registration Country : USA

blank

03

World Vaccine Congress
Not Confirmed
arrow
arrow
World Vaccine Congress
Not Confirmed

ARFORMOTEROL TARTRATE

Brand Name : ARFORMOTEROL TARTRATE

Dosage Form : SOLUTION;INHALATION

Dosage Strength : EQ 0.015MG BASE/2ML

Packaging :

Approval Date : 2022-05-10

Application Number : 214779

Regulatory Info : RX

Registration Country : USA

blank

04

Biological E

India
World Vaccine Congress
Not Confirmed
arrow

Biological E

India
arrow
World Vaccine Congress
Not Confirmed

ARFORMOTEROL TARTRATE

Brand Name : ARFORMOTEROL TARTRATE

Dosage Form : SOLUTION;INHALATION

Dosage Strength : EQ 0.015MG BASE/2ML

Packaging :

Approval Date : 2021-06-22

Application Number : 213762

Regulatory Info : RX

Registration Country : USA

blank

05

CF PharmTech

China
World Vaccine Congress
Not Confirmed
arrow

CF PharmTech

China
arrow
World Vaccine Congress
Not Confirmed

ARFORMOTEROL TARTRATE

Brand Name : ARFORMOTEROL TARTRATE

Dosage Form : SOLUTION;INHALATION

Dosage Strength : EQ 0.015MG BASE/2ML

Packaging :

Approval Date : 2024-05-17

Application Number : 216303

Regulatory Info : RX

Registration Country : USA

blank

06

Lupin Ltd

India
World Vaccine Congress
Not Confirmed
arrow

Lupin Ltd

India
arrow
World Vaccine Congress
Not Confirmed

ARFORMOTEROL TARTRATE

Brand Name : BROVANA

Dosage Form : SOLUTION;INHALATION

Dosage Strength : EQ 0.015MG BASE/2ML

Packaging :

Approval Date : 2006-10-06

Application Number : 21912

Regulatory Info : RX

Registration Country : USA

blank

07

Lupin Ltd

India
World Vaccine Congress
Not Confirmed
arrow

Lupin Ltd

India
arrow
World Vaccine Congress
Not Confirmed

ARFORMOTEROL TARTRATE

Brand Name : ARFORMOTEROL TARTRATE

Dosage Form : SOLUTION;INHALATION

Dosage Strength : EQ 0.015MG BASE/2ML

Packaging :

Approval Date : 2022-02-07

Application Number : 213068

Regulatory Info : RX

Registration Country : USA

blank

08

World Vaccine Congress
Not Confirmed
arrow
arrow
World Vaccine Congress
Not Confirmed

ARFORMOTEROL TARTRATE

Brand Name : ARFORMOTEROL TARTRATE

Dosage Form : SOLUTION;INHALATION

Dosage Strength : EQ 0.015MG BASE/2ML

Packaging :

Approval Date : 2022-11-15

Application Number : 216128

Regulatory Info : RX

Registration Country : USA

blank

09

World Vaccine Congress
Not Confirmed
arrow
arrow
World Vaccine Congress
Not Confirmed

ARFORMOTEROL TARTRATE

Brand Name : ARFORMOTEROL TARTRATE

Dosage Form : SOLUTION;INHALATION

Dosage Strength : EQ 0.015MG BASE/2ML

Packaging :

Approval Date : 2021-11-09

Application Number : 200293

Regulatory Info : RX

Registration Country : USA

blank

10

World Vaccine Congress
Not Confirmed
arrow
arrow
World Vaccine Congress
Not Confirmed

ARFORMOTEROL TARTRATE

Brand Name : ARFORMOTEROL TARTRATE

Dosage Form : SOLUTION;INHALATION

Dosage Strength : EQ 0.015MG BASE/2ML

Packaging :

Approval Date : 2022-03-02

Application Number : 214736

Regulatory Info : RX

Registration Country : USA

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

read-more
read-more

Controlled & Modified Release

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty